Utilizing Three-Dimensional Culture Methods to Improve High-Throughput Drug Screening in Anaplastic Thyroid Carcinoma is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: T32GM007628-42
National Cancer Institute
Grant: 5F31C261060-02
National Cancer Institute
Grant: R50CA243783
National Cancer Institute
Grant: R50CA211206
National Cancer Institute
Grant: R01CA244188
National Cancer Institute
Grant: 1K08CA240901-01A1
The role of Wnt signaling in aggressive thyroid carcinoma
National Cancer Institute
Grant: K12CA090625
National Cancer Institute
Grant: P30CA68485
National Institute of General Medical Sciences
Grant: R35GM122516
American Thyroid Association
Grant: 2019-0000000090
American Cancer Society
Grant: 133934-CSDG-19-216-01-TBG
Vanderbilt CTSA
Grant: UL1TR00044
National Institutes of Health
Grant: 1R50CA243783-01
Research Specialist in Cancer Systems Biology
National Institutes of Health
Grant: 2K12CA090625-06
Vanderbilt Clinical Oncology Research Career Development Program
National Institutes of Health
Grant: 5R01CA244188-03
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
National Institutes of Health
Grant: 5T32GM007628-43
Training in Pharmacological Sciences
National Institutes of Health
Grant: 3R35GM122516-07S1
Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
National Institutes of Health
Grant: 5UL1TR002243-05
Vanderbilt Institute for Clinical and Translational Research (VICTR)
National Institutes of Health
Grant: 3P30CA068485-23S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5R50CA211206-08
Cancer Pharmacologist and HTS Scientist
NIH HHS
Grant: S10 OD028719
FWCI
0.21
Citation Percentile
0.4%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals